Skip to main content

Milestone Pharmaceuticals Inc.

MIST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001408443

No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q3 2026, worth $43.6M in total; no superinvestor holds it.

Holders of 5% or more of MIST

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Milestone Pharmaceuticals Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MIST
HolderLatest formStakeChangeFirst filedLatest filingFiling
Propel Bio Management, LLC13G/A10.10%12.6M shares+0.20 ppfrom 9.90%Dec 23, 20252 filingsNov 20, 2026SEC
RTW Investments, LP13G/A9.90%12.4M shares0.00 ppfrom 9.90%Feb 12, 20216 filingsMay 15, 2026SEC
Pavaki Capital Management LLC13G7.30%9.07M sharesNewAug 7, 20261 filingAug 7, 2026SEC
Adage Capital Management, L.P.13G/A6.37%8.00M shares−3.62 ppfrom 9.99%Nov 13, 20252 filingsMay 13, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

48 Schedule 13D and 13G filings on Milestone Pharmaceuticals Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MIST
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 20, 20261:27 PM ETPropel Bio Management, LLCand 3 others13G/A10.10%12.6M shares+0.20 ppfrom 9.90%Nov 19, 2026SEC
Aug 7, 20261:49 PM ETPavaki Capital Management LLCand 2 others13G7.30%9.07M sharesNewDec 31, 2025SEC
May 15, 20268:26 AM ETRTW Investments, LPand 1 other13G/A9.90%12.4M shares0.00 ppfrom 9.90%Mar 31, 2026SEC
May 13, 20269:09 AM ETAdage Capital Management, L.P.and 2 others13G/A6.37%8.00M shares−3.62 ppfrom 9.99%Mar 31, 2026SEC
Mar 26, 20265:37 PM ETTrails Edge Capital Partners, LPand 2 others13G/A4.30%5.33M shares−5.60 ppfrom 9.90%Below 5%Mar 20, 2026SEC
Dec 23, 20252:20 PM ETPropel Bio Management, LLCand 3 others13G9.90%8.86M sharesNewJul 11, 2025SEC
Nov 14, 20254:05 PM ETTrails Edge Capital Partners, LPand 2 others13G/A9.90%9.02M shares0.00 ppfrom 9.90%Sep 30, 2025SEC
Nov 14, 20258:30 AM ETRTW Investments, LPand 1 other13G/A9.90%9.16M shares−0.09 ppfrom 9.99%Sep 30, 2025SEC
Nov 13, 20259:10 AM ETAdage Capital Management, L.P.and 2 others13G9.99%8.66M sharesNewSep 30, 2025SEC
Jul 21, 20254:30 PM ETTrails Edge Capital Partners, LPand 2 others13G9.90%8.85M sharesNewJul 14, 2025SEC
Apr 30, 20254:00 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A0.60%322.1K shares–Below 5%Mar 31, 2025SEC
Apr 22, 20259:32 AM ETBlackRock, Inc.13G/A0.00%0 shares−7.60 ppfrom 7.60%Below 5%Mar 31, 2025SEC
Feb 14, 20259:00 AM ETRTW Investments, LPand 1 other13G/A9.99%5.64M shares–Dec 31, 2024SEC
Feb 5, 20251:23 PM ETBlackRock, Inc.13G/A7.60%4.05M shares–Dec 31, 2024SEC
Oct 29, 2024Integrated Core Strategies (US) LLC13G/AOld format–––SEC
Jul 16, 2024Alta Fundamental Advisers LLC13D/AOld format–––SEC
Feb 14, 2024Venrock Healthcare Capital Partners III, L.P.13G/AOld format–––SEC
Feb 14, 2024RTW Investments, LP13G/AOld format–––SEC
Feb 9, 20247:41 PM ETGoldman Sachs Group Inc13G/AOld format–––SEC
Jan 29, 2024Integrated Core Strategies (US) LLC13G/AOld format–––SEC
Jan 24, 20242:27 PM ETBlackRock Inc.13G/AOld format–––SEC
Nov 9, 2023Alta Fundamental Advisers LLC13DOld format–New–SEC
Feb 14, 2023Ikarian Capital, LLC13G/AOld format–––SEC
Feb 14, 2023Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2023Venrock Healthcare Capital Partners III, L.P.13G/AOld format–––SEC
Feb 14, 2023OrbiMed Capital LLC13G/AOld format–––SEC
Feb 14, 2023Boxer Capital, LLC13G/AOld format–––SEC
Feb 13, 20239:06 AM ETBlackRock Inc.13G/AOld format–––SEC
Jan 19, 20239:19 AM ETGoldman Sachs Group Inc13GOld format–New–SEC
Jan 18, 2023Integrated Core Strategies (US) LLC13G/AOld format–––SEC
Oct 31, 2022Integrated Core Strategies (US) LLC13GOld format–New–SEC
Oct 24, 2022Novo Holdings A/S13D/AOld format–––SEC
Sep 26, 2022Novo Holdings A/S13D/AOld format–––SEC
Sep 20, 2022Venrock Healthcare Capital Partners III, L.P.13GOld format–New–SEC
Feb 14, 2022Boxer Capital, LLC13G/AOld format–––SEC
Feb 14, 2022Ikarian Capital, LLC13G/AOld format–––SEC
Feb 14, 2022Ra Capital Management, L.P.13G/AOld format–––SEC
Feb 14, 2022RTW Investments, LP13G/AOld format–––SEC
Feb 11, 2022OrbiMed Capital LLC13G/AOld format–––SEC
Feb 16, 2021Boxer Capital, LLC13G/AOld format–––SEC
Feb 16, 2021Forbion Capital Fund III Cooperatief U.A.13G/AOld format–––SEC
Feb 16, 2021Ra Capital Management, L.P.13GOld format–New–SEC
Feb 16, 2021Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 12, 2021RTW Investments, LP13G/AOld format–––SEC
Feb 12, 2021Fonds de Solidarite des Travailleurs du Quebec13G/AOld format–––SEC
Feb 12, 2021OrbiMed Capital LLC13GOld format–New–SEC
Jan 21, 2021Domain Partners VIII, L.P.13G/AOld format–––SEC
Jan 11, 2021Ikarian Capital, LLC13GOld format–New–SEC

Form 144: proposed insider sales

3 notices from officers, directors and other affiliates planning to sell Milestone Pharmaceuticals Inc. shares, newest first.

Form 144 notices for MIST
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Apr 16, 20264:12 PM ETJoseph OlivetoDirector · Officer36.5K$80.3KApr 16, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 8, 20264:25 PM ETJoseph OlivetoDirector · Officer79.5K$170.9KJan 8, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Jan 7, 20264:22 PM ETJoseph OlivetoOfficer500$1.02KJan 7, 202610b5-1Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC